ZYME Q3 2024 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M-3.1% YoY

Gross Profit

$16M100.0% margin

Operating Income

-$34M-213.8% margin

Net Income

-$30M-186.6% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

-16.9%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$487M

Total Liabilities

$120M

Stockholders' Equity

$367M

Cash & Equivalents

$122M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$17M	-3.1%
Gross Profit	$16M	$17M	-3.1%
Operating Income	-$34M	-$33M	-2.9%
Net Income	-$30M	-$29M	-4.1%

Revenue Segments

Milestone Revenue

$3M77%

Research Support Payments And Other Service

$764,00023%